{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T22:13:58Z","timestamp":1762899238552},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography B"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.jchromb.2016.02.038","type":"journal-article","created":{"date-parts":[[2016,3,16]],"date-time":"2016-03-16T22:41:26Z","timestamp":1458168086000},"page":"85-89","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["An HPLC\u2013MS method for the quantification of new acetylcholinesterase inhibitor PC 48 (7-MEOTA-donepezil like compound) in rat plasma: Application to a pharmacokinetic study"],"prefix":"10.1016","volume":"1020","author":[{"given":"Martin","family":"Mzik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Korabecny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugenie","family":"Nepovimova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viktor","family":"Vo\u0159\u00ed\u0161ek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vladimir","family":"Pali\u010dka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamil","family":"Kuca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jana","family":"Zdarova Karasova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchromb.2016.02.038_bib0005","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer\u2019s disease: progress and problems on the road to therapeutics","volume":"294","author":"Hardy","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.jchromb.2016.02.038_bib0010","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0891-5849(96)00629-6","article-title":"Oxidative stress hypothesis in Alzheimer's disease","volume":"23","author":"Markesbery","year":"1997","journal-title":"Free Radical Bio. Med."},{"key":"10.1016\/j.jchromb.2016.02.038_bib0015","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1152\/physrev.2001.81.2.741","article-title":"Alzheimer\u2019s disease: genes, proteins and therapy","volume":"81","author":"Selkoe","year":"2001","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.jchromb.2016.02.038_bib0020","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nature05292","article-title":"Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases","volume":"443","author":"Lin","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.jchromb.2016.02.038_bib0025","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1007\/s00702-006-0579-2","article-title":"The significance of the cholinergic system in the brain during aging and in Alzheimer\u2019s disease","volume":"113","author":"Schliebs","year":"2006","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.jchromb.2016.02.038_bib0030","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1046\/j.1365-2125.1999.00026.x","article-title":"Acetylcholinesterase inhibitors in Alzheimer\u2019s disease","volume":"48","author":"McGleenon","year":"1999","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.jchromb.2016.02.038_bib0035","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.ejmech.2014.05.066","article-title":"7-MEOTA-donepezil like compounds as cholinesterase inhibitors: synthesis, pharmacological evaluation, molecular modeling and QSAR studies","volume":"82","author":"Korabecny","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jchromb.2016.02.038_bib0040","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.2174\/092986710791111206","article-title":"Tacrine derivatives and Alzheimer\u2019s disease","volume":"17","author":"Tumiatti","year":"2010","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.jchromb.2016.02.038_bib0045","first-page":"299","article-title":"Advances in synthesis of tacrine derivatives as potential-drugs for treatment of Alzheimer\u2019s disease","volume":"35","author":"Patocka","year":"1994","journal-title":"Homeost. Health Dis."},{"key":"10.1016\/j.jchromb.2016.02.038_bib0050","doi-asserted-by":"crossref","first-page":"893","DOI":"10.2174\/1567205011310080011","article-title":"A resurrection of 7-MEOTA: a comparison with tacrine","volume":"10","author":"Soukup","year":"2013","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.jchromb.2016.02.038_bib0055","first-page":"303","article-title":"Donepezil in Alzheimer\u2019s disease: from conventional trials to pharmacogenetics","volume":"3","author":"Cacabelos","year":"2007","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.jchromb.2016.02.038_bib0060","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1159\/000106895","article-title":"The efficacy and safety of donepezil in patients with Alzheimer's disease: results of a US multicentre, randomized, double-blind, placebo-controlled trial","volume":"7","author":"Rogers","year":"1996","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.jchromb.2016.02.038_bib0065","doi-asserted-by":"crossref","first-page":"189","DOI":"10.4149\/gpb_2014036","article-title":"Cholinergic properties of new 7-methoxytacrine-donepezil derivatives","volume":"34","author":"Sepsova","year":"2015","journal-title":"Gen. Physiol. Biophys."},{"key":"10.1016\/j.jchromb.2016.02.038_bib0070","series-title":"Guidance for industry-Bioanalytical method validation","author":"US Food and Drug Administration","year":"2001"},{"key":"10.1016\/j.jchromb.2016.02.038_bib0075","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s12640-012-9329-4","article-title":"Time-dependent changes of oxime K027 concentrations in different parts of rat central nervous system","volume":"23","author":"Karasova","year":"2013","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.jchromb.2016.02.038_bib0080","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.toxlet.2013.04.013","article-title":"Hyaluronidase Its effects on HI-6 dichloride and dimethanesulphonate pharmacokinetic profile in pigs","volume":"220","author":"Karasova","year":"2013","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.jchromb.2016.02.038_bib0085","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.chroma.2012.08.036","article-title":"Performance characteristics of new superficially porous particles","volume":"1258","author":"Destefano","year":"2012","journal-title":"J. Chromatogr. A"}],"container-title":["Journal of Chromatography B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023216301258?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023216301258?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,11,3]],"date-time":"2019-11-03T11:42:08Z","timestamp":1572781328000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570023216301258"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":17,"alternative-id":["S1570023216301258"],"URL":"https:\/\/doi.org\/10.1016\/j.jchromb.2016.02.038","relation":{},"ISSN":["1570-0232"],"issn-type":[{"value":"1570-0232","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An HPLC\u2013MS method for the quantification of new acetylcholinesterase inhibitor PC 48 (7-MEOTA-donepezil like compound) in rat plasma: Application to a pharmacokinetic study","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchromb.2016.02.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}